Brenton L. Saunders
| Brent Saunders | |
|---|---|
| Born |
Brenton L. Saunders February 6, 1970 Arizona, US |
| Nationality | American |
| Education | Parkland High School |
| Alma mater |
University of Pittsburgh Temple University |
| Occupation | CEO, Allergan |
| Salary | $36,613,829 (total compensation, 2014)[1] |
| Spouse(s) | married |
| Children | 2 daughters |
| Parent(s) |
Charles Saunders Sheila Saunders |
| Website | http://www.allergan.com/ |
Brenton L. Saunders, also known as Brent Saunders (born February 6, 1970), is the CEO of Allergan, a pharmaceutical company since 2014, and co-founder of Health Care Compliance Association in 1995.
Early life
He was born in Arizona on February 6, 1970,[2] the son of Charles Saunders, a retired urologist, and his wife Sheila. He has a twin brother Wayne and a sister Reed, and they grew up on Cedarwood Road in South Whitehall, Pennsylvania. His parents co-founded Senior Solutions, the first geriatric-care management agency in Lehigh Valley. His father is chair of the board of trustees of St. Luke's University Health Network.[3]
He graduated from Parkland High School in 1988.[3] He received a BA in economics and east asian studies from the University of Pittsburgh in 1992, an MBA from Temple University Fox School of Business and Management in 1996, and a JD from Temple University Beasley School of Law in 1996.[4]
Career
1995-2000
He co-founded Health Care Compliance Association in 1995. He served as the chairman of the New York chapter of the American Heart Association. He also serves on the transition team for New Jersey Governor-elect Chris Christie. In 1997, he was named Compliance Officer of the Year at Health Care Compliance Association. He served as the chief compliance officer for Coventry Health Care and for Thomas Jefferson University and Health System. He served as senior vice president of Compliance, Legal, and Regulatory at Home Care Corp. of America. He served as the chief risk officer of Coventry Health Care from 1998 to 1999.
2000-2010
He was a Partner and Head of the Compliance Business Advisory Group at PricewaterhouseCoopers LLP from 2000 to 2003. He joined Schering-Plough from PricewaterhouseCoopers, where he led its compliance business advisory services group. He served as a Senior Executive of Schering-Plough from 2003 to 2010 and served as its President of Global Consumer Health Care. He served as the Head of Integration for both Schering-Plough's merger with Merck & Co. He served as Senior Vice President of Global Compliance and Business Practices of Schering-Plough Corp. from November 1, 2003 to February 20, 2007. He served as the President of Consumer Health Care and Senior Vice President of Schering-Plough Corp. since February 2007.
2010 to present
He served as the CEO of Bausch & Lomb Incorporated and Bausch & Lomb Holdings Incorporated since March 15, 2010. He served as a Special Adviser of General Atlantic LLC. From 2010 to February 2013, he served as President of Bausch & Lomb Holdings Incorporated. He served as an Advisor of Valeant Pharmaceuticals since August 2013. Mr. Saunders served as the C.E.O. and President of Forest Laboratories from October 1, 2013 to 2014.[1]
Affiliations
He has been a Director of Actavis plc since July 1, 2014. He serves as a Director of Actavis Funding SCS. He serves on the Boards of electroCore LLC and the Overlook Hospital Foundation. He has been a Member of Upstate New York Regional Advisory Board at The Federal Reserve Bank of New York since June 9, 2010. He served as a Director of Forest Laboratories Inc. since August 2011. He served as Director of Bausch & Lomb Holdings Incorporated and Bausch & Lomb Incorporated since March 15, 2010.[1]
Personal life
He is married and has two daughters.[2]
References
- 1 2 3 "Executive Profile* Brenton L. Saunders J.D.". Bloomberg L.P. Retrieved 24 November 2015.
- 1 2 "The Botox initiation of Brent Saunders, Actavis chief executive". Financial Times. 17 May 2015. Retrieved 24 November 2015.
- 1 2 Harris, Jon (19 October 2015). "Brent Saunders, Parkland grad, is the Lehigh Valley's $150 billion dealmaker". The Morning Call. Retrieved 24 November 2015.
- ↑ "executive-leadership".
| Business positions | ||
|---|---|---|
| Preceded by Paul Bisaro Acting |
Chief Executive Officer of Actavis 2014-present |
Incumbent |